FDA cardiovascular devices division
This article was originally published in The Gray Sheet
Executive Summary
Acting director of the office of device evaluation's division of cardiovascular, respiratory and neurological devices will be Thomas Callahan, effective July 10, FDA says. Callahan, a 15- year FDA veteran, currently is an associate director of ODE's division of general and restorative devices. He will replace Abhijit Acharya, who is leaving FDA on July 10 to join the Arlington, Virginia-based Biometric Research Institute ("The Gray Sheet" May 17, In Brief).